These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 34905269)

  • 1. Clinical characteristics of COVID-19 in solid organ transplant recipients following COVID-19 vaccination: A multicenter case series.
    Saharia KK; Anjan S; Streit J; Beekmann SE; Polgreen PM; Kuehnert M; Segev DL; Baddley JW; Miller RA;
    Transpl Infect Dis; 2022 Apr; 24(2):e13774. PubMed ID: 34905269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating clinical effectiveness of SARS-CoV-2 vaccine in solid organ transplant recipients: A propensity score matched analysis.
    Tucker M; Azar MM; Cohen E; Gan G; Deng Y; Foppiano Palacios C; Malinis M
    Transpl Infect Dis; 2022 Aug; 24(4):e13876. PubMed ID: 35684932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beyond prevention: Unveiling the benefits of triple vaccination on COVID-19 severity and resource utilization in solid organ transplant recipients.
    Zhang JR; Johnson JC; Preble RG; Mujtaba M; Lea AS; Stevenson HL; Kueht M
    Transpl Immunol; 2024 Jun; 84():102048. PubMed ID: 38641149
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical effectiveness of COVID-19 vaccination in solid organ transplant recipients.
    Aslam S; Adler E; Mekeel K; Little SJ
    Transpl Infect Dis; 2021 Oct; 23(5):e13705. PubMed ID: 34324256
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immune Response after the Fourth Dose of SARS-CoV-2 mRNA Vaccine Compared to Natural Infection in Three Doses' Vaccinated Solid Organ Transplant Recipients.
    Busà R; Russelli G; Miele M; Sorrentino MC; Di Bella M; Timoneri F; Di Mento G; Mularoni A; Vitulo P; Conaldi PG; Bulati M
    Viruses; 2022 Oct; 14(10):. PubMed ID: 36298854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breakthrough COVID-19 after SARS-CoV-2 vaccination in solid organ transplant recipients: An analysis of symptomatic cases and monoclonal antibody therapy.
    Yetmar ZA; Bhaimia E; Bierle DM; Ganesh R; Razonable RR
    Transpl Infect Dis; 2022 Apr; 24(2):e13779. PubMed ID: 34932874
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Outcomes of SARS-CoV-2 Infection in Unvaccinated Compared With Vaccinated Solid Organ Transplant Recipients: A Propensity Matched Cohort Study.
    Hall VG; Al-Alahmadi G; Solera JT; Marinelli T; Cardinal H; Prasad GVR; De Serres SA; Isaac D; Mainra R; Lamarche C; Sapir-Pichhadze R; Gilmour S; Matelski J; Humar A; Kumar D
    Transplantation; 2022 Aug; 106(8):1622-1628. PubMed ID: 35502801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Susceptibility to SARS-CoV-2 Infection and Immune Responses to COVID-19 Vaccination Among Recipients of Solid Organ Transplants.
    Subramanian V
    J Infect Dis; 2023 Aug; 228(Suppl 1):S34-S45. PubMed ID: 37539762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Humoral immunity against SARS-CoV-2 variants including omicron in solid organ transplant recipients after three doses of a COVID-19 mRNA vaccine.
    Saharia KK; Husson JS; Niederhaus SV; Iraguha T; Avila SV; Yoo YJ; Hardy NM; Fan X; Omili D; Crane A; Carrier A; Xie WY; Vander Mause E; Hankey K; Bauman S; Lesho P; Mannuel HD; Ahuja A; Mathew M; Avruch J; Baddley J; Goloubeva O; Shetty K; Dahiya S; Rapoport AP; Luetkens T; Atanackovic D
    Clin Transl Immunology; 2022; 11(5):e1391. PubMed ID: 35505864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Coronavirus disease 2019 vaccination is protective of clinical disease in solid organ transplant recipients.
    Aslam S; Liu J; Sigler R; Syed RR; Tu XM; Little SJ; De Gruttola V
    Transpl Infect Dis; 2022 Apr; 24(2):e13788. PubMed ID: 34989104
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Humoral immune response following a third SARS-CoV-2 mRNA vaccine dose in solid organ transplant recipients compared with matched controls.
    Balsby D; Nilsson AC; Petersen I; Lindvig SO; Davidsen JR; Abazi R; Poulsen MK; Holden IK; Justesen US; Bistrup C; Johansen IS
    Front Immunol; 2022; 13():1039245. PubMed ID: 36569919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Breakthrough Infections Following mRNA SARS-CoV-2 Vaccination in Kidney Transplant Recipients.
    Mazuecos A; Villanego F; Zarraga S; López V; Oppenheimer F; Llinàs-Mallol L; Hernández AM; Rivas A; Ruiz-Fuentes MC; Toapanta NG; Jiménez C; Cabello S; Beneyto I; Aladrén MJ; Rodríguez-Benot A; Canal C; Molina M; Pérez-Flores I; Saura IM; Gavela E; Franco A; Lorenzo I; Galeano C; Tabernero G; Pérez-Tamajón L; Martín-Moreno PL; Fernández-Girón F; Siverio O; Labrador PJ; De Arriba G; Simal F; Cruzado L; Moina I; Alcalde G; Sánchez-Álvarez E; Pascual J; Crespo M;
    Transplantation; 2022 Jul; 106(7):1430-1439. PubMed ID: 35384924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on COVID-19 vaccination in pediatric solid organ transplant recipients.
    Dulek DE; Ardura MI; Green M; Michaels MG; Chaudhuri A; Vasquez L; Danziger-Isakov L; Posfay-Barbe KM; McCulloch MI; L'Huillier AG; Benden C
    Pediatr Transplant; 2022 Aug; 26(5):e14235. PubMed ID: 35060251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effect of COVID 19 vaccination on kidney recipients.
    Marzieh L; Elahe P; Habib R; Maryam P; Arefeh J; Elnaz E; Sanaz D
    Transpl Immunol; 2022 Oct; 74():101658. PubMed ID: 35777613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study.
    Heldman MR; Kates OS; Safa K; Kotton CN; Georgia SJ; Steinbrink JM; Alexander BD; Hemmersbach-Miller M; Blumberg EA; Crespo MM; Multani A; Lewis AV; Eugene Beaird O; Haydel B; La Hoz RM; Moni L; Condor Y; Flores S; Munoz CG; Guitierrez J; Diaz EI; Diaz D; Vianna R; Guerra G; Loebe M; Rakita RM; Malinis M; Azar MM; Hemmige V; McCort ME; Chaudhry ZS; Singh P; Hughes K; Velioglu A; Yabu JM; Morillis JA; Mehta SA; Tanna SD; Ison MG; Tomic R; Candace Derenge A; van Duin D; Maximin A; Gilbert C; Goldman JD; Sehgal S; Weisshaar D; Girgis RE; Nelson J; Lease ED; Limaye AP; Fisher CE;
    Am J Transplant; 2021 Aug; 21(8):2774-2784. PubMed ID: 34008917
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Longitudinal outcomes of COVID-19 in solid organ transplant recipients from 2020 to 2023.
    Solera JT; Árbol BG; Mittal A; Hall V; Marinelli T; Bahinskaya I; Selzner N; McDonald M; Schiff J; Sidhu A; Humar A; Kumar D
    Am J Transplant; 2024 Jul; 24(7):1303-1316. PubMed ID: 38499087
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of SARS-CoV-2 variant breakthrough infection in fully immunized solid organ transplant recipients.
    Almaghrabi RS; Alhamlan FS; Dada A; Al-Tawfiq JA; Al Hroub MK; Saeedi MF; Alamri M; Alhothaly B; Alqasabi A; Al-Qahtani AA; Al-Omari A; Alshukairi AN
    J Infect Public Health; 2022 Jan; 15(1):51-55. PubMed ID: 34906898
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differences in Antibody Responses Between an Inactivated SARS-CoV-2 Vaccine and the BNT162b2 mRNA Vaccine in Solid-Organ Transplant Recipients.
    Erol Ç; Yanık Yalçın T; Sarı N; Bayraktar N; Ayvazoğlu Soy E; Yavuz Çolak M; Azap Ö; Arslan H; Haberal M
    Exp Clin Transplant; 2021 Dec; 19(12):1334-1340. PubMed ID: 34951350
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of severe COVID in solid organ transplant recipient.
    Barreiro P; Candel FJ; Carretero MM; San Román J
    Rev Esp Quimioter; 2023 Nov; 36 Suppl 1(Suppl 1):15-17. PubMed ID: 37997864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A single-center review of pre-exposure prophylaxis with tixagevimab-cilgavimab in solid organ transplant recipients.
    Morado F; Davoudi R; Kawewat-Ho P; Nanda N; Cartus R; Shaikh SA
    Transpl Infect Dis; 2023 Aug; 25(4):e14086. PubMed ID: 37314092
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.